|
ZNF329 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.96860030685787E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.91469999644545E-08 |
| Normal-vs-Stage2 |
2.182400E-03 |
| Normal-vs-Stage3 |
5.70759994822367E-09 |
| Normal-vs-Stage4 |
1.00099994959635E-09 |
| Stage1-vs-Stage2 |
1.936250E-01 |
| Stage1-vs-Stage3 |
1.069430E-01 |
| Stage1-vs-Stage4 |
1.074170E-02 |
| Stage2-vs-Stage3 |
2.306200E-02 |
| Stage2-vs-Stage4 |
3.084500E-03 |
| Stage3-vs-Stage4 |
3.629400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.24310003904549E-09 |
| Normal-vs-AfricanAmerican |
1.875910E-02 |
| Normal-vs-Asian |
3.65450000039402E-07 |
| Caucasian-vs-AfricanAmerican |
1.381240E-01 |
| Caucasian-vs-Asian |
5.862400E-01 |
| AfricanAmerican-vs-Asian |
7.703600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.98760000014175E-07 |
| Normal-vs-Female |
1.40400002734964E-09 |
| Male-vs-Female |
9.098000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.7182999951545E-08 |
| Normal-vs-Age(41-60Yrs) |
2.29330000545147E-08 |
| Normal-vs-Age(61-80Yrs) |
4.90749999526585E-08 |
| Normal-vs-Age(81-100Yrs) |
3.914000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.422000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.657600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.340400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.838200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.787800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.775000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.58100999999577E-05 |
| Classical-VS-Follicular |
7.725800E-01 |
| Classical-VS-Other |
9.316400E-01 |
| Classical-VS-Normal |
1.4658000035972E-08 |
| Tall-VS-Follicular |
1.136500E-03 |
| Tall-VS-Other |
4.341800E-01 |
| Tall-VS-Normal |
7.88125120720906E-12 |
| Follicular-VS-Other |
9.789600E-01 |
| Follicular-VS-Normal |
2.15339999999342E-05 |
| Other-VS-Normal |
2.165600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.20360000042264E-07 |
| Normal-vs-N1 |
6.34881036631896E-12 |
| N0-vs-N1 |
9.63280000000344E-05 |
|
|
